These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33882369)
1. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis. Zhu HY; Gao YJ; Wang Y; Liang C; Zhang ZX; Chen Y Transl Oncol; 2021 Jul; 14(7):101088. PubMed ID: 33882369 [TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203/VEGFA Axis. Chen LJ; Yuan MX; Ji CY; Zhang YB; Peng YM; Zhang T; Gao HQ; Sheng XY; Liu ZY; Xie WX; Yin Q Pathobiology; 2020; 87(3):161-170. PubMed ID: 32182608 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum to " LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis" [Translational Oncology 14(7):101088]. Zhu HY; Gao YJ; Wang Y; Liang C; Zhang ZX; Chen Y Transl Oncol; 2021 Oct; 14(10):101143. PubMed ID: 34303156 [No Abstract] [Full Text] [Related]
4. LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer. Sun H; He L; Ma L; Lu T; Wei J; Xie K; Wang X Oncotarget; 2017 Dec; 8(66):110552-110565. PubMed ID: 29299168 [TBL] [Abstract][Full Text] [Related]
5. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921 [TBL] [Abstract][Full Text] [Related]
7. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678 [TBL] [Abstract][Full Text] [Related]
8. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p. Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CRNDE promotes proliferation, migration and invasion in prostate cancer through miR-101/Rap1A. Chen JH; Tong W; Pu XF; Wang JZ Neoplasma; 2020 May; 67(3):584-594. PubMed ID: 32182086 [TBL] [Abstract][Full Text] [Related]
10. CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis. Ren L; Yang S; Cao Q; Tian J Onco Targets Ther; 2021; 14():355-366. PubMed ID: 33469312 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis. Wang J; Song J; Li Y; Shao J; Xie Z; Sun K Int Immunopharmacol; 2020 Feb; 79():105933. PubMed ID: 31877497 [TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway. Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p. Jing H; Xia H; Qian M; Lv X Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145. Hu CE; Du PZ; Zhang HD; Huang GJ Cell Physiol Biochem; 2017; 42(1):13-21. PubMed ID: 28490034 [TBL] [Abstract][Full Text] [Related]
15. lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis. Gao J; Chen Q; Zhao Y; Hou R Onco Targets Ther; 2020; 13():9225-9234. PubMed ID: 32982309 [TBL] [Abstract][Full Text] [Related]
16. LncRNA CRNDE regulates trophoblast cell proliferation, invasion, and migration via modulating miR-1277. Zhu H; Kong L Am J Transl Res; 2019; 11(9):5905-5918. PubMed ID: 31632559 [TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 Axis. Liu C; Hou J; Shan F; Wang L; Lu H; Ren T Onco Targets Ther; 2020; 13():4931-4942. PubMed ID: 32581554 [TBL] [Abstract][Full Text] [Related]
18. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. Chen Z; Yu C; Zhan L; Pan Y; Chen L; Sun C Am J Cancer Res; 2016; 6(10):2299-2309. PubMed ID: 27822419 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CRNDE exacerbates NPC advancement mediated by the miR-545-5p/CCND2 axis. Ge S; Jiang C; Li M; Cheng Z; Feng X Cancer Cell Int; 2021 Dec; 21(1):650. PubMed ID: 34863152 [TBL] [Abstract][Full Text] [Related]
20. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]